Roles of Cx 43 and AKAP 95 in ovarian cancer tissues in G 1 / S phase

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Synergistic effects of AKAP95, Cyclin D1, Cyclin E1, and Cx43 in the development of rectal cancer.

  2015cited by this paper
• Targeting the Notch signaling pathway in cancer therapeutics

  2014cited by this paper
• Expression and significance of Rac1, Pak1 and Rock1 in gastric carcinoma2

  2013cited by this paper
• Resistance to CDK2 Inhibitors Is Associated with Selection of Polyploid Cells in CCNE1-Amplified Ovarian Cancer

  2013cited by this paper
• Expression of cyclin d1 and its association with disease characteristics in bladder cancer.

  2013cited by this paper
• Recurrent Ovarian Cancer: When and How to Treat

  2011cited by this paper
• Cyclin D as a therapeutic target in cancer

  2011cited by this paper
• Tailoring to RB: tumour suppressor status and therapeutic response

  2008cited by this paper
• Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis

  2006cited by this paper
• G1/S Cyclins Interact with Regulatory Subunit of PKA via A-Kinase Anchoring Protein, AKAP95

  2006cited by this paper
• Differential expression of connexin 43 in gastrointestinal stromal tumours of gastric and small intestinal origin

  2005cited by this paper
• A novel partner for D-type cyclins: protein kinase A-anchoring protein AKAP95.

  2004cited by this paper
• Requirement for cyclin D3 in lymphocyte development and T cell leukemias.

  2003cited by this paper
• A novel route for connexin 43 to inhibit cell proliferation: negative regulation of S-phase kinase-associated protein (Skp 2).

  2003cited by this paper
• Structural and Functional Diversity of Connexin Genes in the Mouse and Human Genome

  2002cited by this paper
• Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index.

  2002cited by this paper
• Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27

  2001cited by this paper
• Immunohistochemical study on the expression of cyclin D1 and E in gastric cancer.

  2000cited by this paper
• Cloning and characterization of AKAP 95, a nuclear protein that associates with the regulatory subunit of type II cAMP-dependent protein kinase.

  1994cited by this paper
• lnterleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin

  1994cited by this paper
• Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle

  1992cited by this paper
• Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family.

  1991cited by this paper
• Molecular oncology

  1991cited by this paper

• Osthole Alleviates Neointimal Hyperplasia in Balloon-Induced Arterial Wall Injury by Suppressing Vascular Smooth Muscle Cell Proliferation and Downregulating Cyclin D1/CDK4 and Cyclin E1/CDK2 Expression

  2021cites this paper